Cargando…
Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
BACKGROUND: Of the genes that control mitochondrial biogenesis and function, ERRα emerges as a druggable metabolic target to be exploited for cancer therapy. Of the genes mutated in cancer, TP53 remains the most elusive to target. A clear understanding of how mitochondrial druggable targets can be a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731476/ https://www.ncbi.nlm.nih.gov/pubmed/33303020 http://dx.doi.org/10.1186/s40170-020-00234-5 |
_version_ | 1783621906108252160 |
---|---|
author | De Vitto, Humberto Ryu, Joohyun Calderon-Aparicio, Ali Monts, Josh Dey, Raja Chakraborty, Abhijit Lee, Mee-Hyun Bode, Ann M. Dong, Zigang |
author_facet | De Vitto, Humberto Ryu, Joohyun Calderon-Aparicio, Ali Monts, Josh Dey, Raja Chakraborty, Abhijit Lee, Mee-Hyun Bode, Ann M. Dong, Zigang |
author_sort | De Vitto, Humberto |
collection | PubMed |
description | BACKGROUND: Of the genes that control mitochondrial biogenesis and function, ERRα emerges as a druggable metabolic target to be exploited for cancer therapy. Of the genes mutated in cancer, TP53 remains the most elusive to target. A clear understanding of how mitochondrial druggable targets can be accessed to exploit the underlying mechanism(s) explaining how p53-deficient tumors promote cell survival remains elusive. METHODS: We performed protein-protein interaction studies to demonstrate that ERRα binds to p53. Moreover, we used gene silencing and pharmacological approaches in tandem with quantitative proteomics analysis by SWATH-MS to investigate the role of the ERRα/p53 complex in mitochondrial biogenesis and function in colon cancer. Finally, we designed in vitro and in vivo studies to investigate the possibility of targeting colon cancers that exhibit defects in p53. RESULTS: Here, we are the first to identify a direct protein-protein interaction between the ligand-binding domain (LBD) of ERRα and the C-terminal domain (CTD) of p53. ERRα binds to p53 regardless of p53 mutational status. Furthermore, we show that the ERRα and p53 complex cooperatively control mitochondrial biogenesis and function. Targeting ERRα creates mitochondrial metabolic stresses, such as production of reactive oxygen species (ROS) and mitochondrial membrane permeabilization (MMP), leading to a greater cytotoxic effect that is dependent on the presence of p53. Pharmacological inhibition of ERRα impairs the growth of p53-deficient cells and of p53 mutant patient-derived colon xenografts (PDX). CONCLUSIONS: Therefore, our data suggest that by using the status of the p53 protein as a selection criterion, the ERRα/p53 transcriptional axis can be exploited as a metabolic vulnerability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40170-020-00234-5. |
format | Online Article Text |
id | pubmed-7731476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77314762020-12-15 Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function De Vitto, Humberto Ryu, Joohyun Calderon-Aparicio, Ali Monts, Josh Dey, Raja Chakraborty, Abhijit Lee, Mee-Hyun Bode, Ann M. Dong, Zigang Cancer Metab Research BACKGROUND: Of the genes that control mitochondrial biogenesis and function, ERRα emerges as a druggable metabolic target to be exploited for cancer therapy. Of the genes mutated in cancer, TP53 remains the most elusive to target. A clear understanding of how mitochondrial druggable targets can be accessed to exploit the underlying mechanism(s) explaining how p53-deficient tumors promote cell survival remains elusive. METHODS: We performed protein-protein interaction studies to demonstrate that ERRα binds to p53. Moreover, we used gene silencing and pharmacological approaches in tandem with quantitative proteomics analysis by SWATH-MS to investigate the role of the ERRα/p53 complex in mitochondrial biogenesis and function in colon cancer. Finally, we designed in vitro and in vivo studies to investigate the possibility of targeting colon cancers that exhibit defects in p53. RESULTS: Here, we are the first to identify a direct protein-protein interaction between the ligand-binding domain (LBD) of ERRα and the C-terminal domain (CTD) of p53. ERRα binds to p53 regardless of p53 mutational status. Furthermore, we show that the ERRα and p53 complex cooperatively control mitochondrial biogenesis and function. Targeting ERRα creates mitochondrial metabolic stresses, such as production of reactive oxygen species (ROS) and mitochondrial membrane permeabilization (MMP), leading to a greater cytotoxic effect that is dependent on the presence of p53. Pharmacological inhibition of ERRα impairs the growth of p53-deficient cells and of p53 mutant patient-derived colon xenografts (PDX). CONCLUSIONS: Therefore, our data suggest that by using the status of the p53 protein as a selection criterion, the ERRα/p53 transcriptional axis can be exploited as a metabolic vulnerability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40170-020-00234-5. BioMed Central 2020-12-10 /pmc/articles/PMC7731476/ /pubmed/33303020 http://dx.doi.org/10.1186/s40170-020-00234-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research De Vitto, Humberto Ryu, Joohyun Calderon-Aparicio, Ali Monts, Josh Dey, Raja Chakraborty, Abhijit Lee, Mee-Hyun Bode, Ann M. Dong, Zigang Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
title | Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
title_full | Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
title_fullStr | Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
title_full_unstemmed | Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
title_short | Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
title_sort | estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731476/ https://www.ncbi.nlm.nih.gov/pubmed/33303020 http://dx.doi.org/10.1186/s40170-020-00234-5 |
work_keys_str_mv | AT devittohumberto estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT ryujoohyun estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT calderonaparicioali estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT montsjosh estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT deyraja estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT chakrabortyabhijit estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT leemeehyun estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT bodeannm estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction AT dongzigang estrogenrelatedreceptoralphadirectlybindstop53andcooperativelycontrolscoloncancergrowththroughtheregulationofmitochondrialbiogenesisandfunction |